Seroba Life Sciences is a European life sciences venture capital firm based in Dublin, focused on backing innovative biotech and medtech companies. Founded in 2002, the firm invests from its Fund IV, which closed at €123M ($134M).
31% of their portfolio is in Healthcare. Their most common stage is series-a (44% of deals). Average disclosed round size is $27.0M (across 7 rounds with reported amounts).
Portfolio
14
Fund Size
$134M
Top Stage
Series A
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
16 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| CCoave Therapeutics | Series A | $32M | Jan 2025 |
 Complement Therapeutics | Series A | — | Apr 2023 |
| CComplement | Series A | — | Apr 2023 |
 Deciphex | Series B | — | Jan 2023 |
 Shorla Oncology | Series B | $35M | Jan 2023 |
 Storm Therapeutics | Series B | $30M | Dec 2022 |
| SSibYlla | Series A | — | Oct 2022 |
| DDECIPHEX LIMITED | Series B | — | Jan 2022 |
| CCoave Therapeutics | Series B | — | Jul 2021 |
 Palliare | Series A | $8M | Jul 2021 |
| SSHORLA PHARMA LIMITED | Series A | $8.3M | Jun 2020 |
 Atlantic Therapeutics | Series B | — | Jan 2019 |
 Endotronix | Series D | $45M | Sep 2018 |
| PPrexton Therapeutics | Unknown | — | Feb 2017 |
| PPrexton Therapeutics | Series B | $31M | Jan 2017 |
 Perfuze | Series A | — | — |
Top Co-Investors
Enterprise Ireland5 shared
Forbion4 shared
Cambridge Innovation Capital3 shared
Kurma Partners3 shared
SV Health Investors2 shared
BioGeneration Ventures2 shared
Gimv2 shared
Hadean Ventures2 shared
M Ventures2 shared
Ysios Capital2 shared
Sunstone Life Science Ventures2 shared
Sunstone Partners2 shared
Earlybird Venture Capital2 shared
Fund+2 shared
Omnes Capital2 shared
EQT Life Sciences1 shared
Illumina Ventures1 shared
SJF Ventures1 shared
Blu Ventures1 shared
Scale Venture Partners1 shared
Last updated: 9 September 2026